Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 16, 2020 - Issue 11
Submit an article Journal homepage
2,808
Views
11
CrossRef citations to date
0
Altmetric
Short Report

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials

Romulo Colindresa GSK, Rockville, MD, USA;b independent Biotech and Vaccines ConsultantView further author information
,
Valentine Wascottec GSK, Wavre, BelgiumORCID Iconhttps://orcid.org/0000-0001-7134-0633View further author information
ORCID Icon,
Alain Brecxd GSK, Rixensart, BelgiumORCID Iconhttps://orcid.org/0000-0001-9378-0541View further author information
ORCID Icon,
Christopher Clarkec GSK, Wavre, Belgium;e Seqirus, Victoria, AustraliaORCID Iconhttps://orcid.org/0000-0001-5539-5319View further author information
ORCID Icon,
Caroline Hervéc GSK, Wavre, BelgiumORCID Iconhttps://orcid.org/0000-0002-0794-8748View further author information
ORCID Icon,
Joon Hyung Kima GSK, Rockville, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6014-3543View further author information
ORCID Icon,
Myron J. Levinf Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USAORCID Iconhttps://orcid.org/0000-0002-7468-106XView further author information
ORCID Icon,
Lidia Oostvogelsc GSK, Wavre, Belgium;g CureVac AG, Tübingen, GermanyORCID Iconhttps://orcid.org/0000-0003-1298-0360View further author information
ORCID Icon,
Toufik Zahafc GSK, Wavre, BelgiumORCID Iconhttps://orcid.org/0000-0002-2049-5210View further author information
ORCID Icon,
Anne Schuinda GSK, Rockville, MD, USAORCID Iconhttps://orcid.org/0000-0003-3544-0682View further author information
ORCID Icon &
Anthony L. Cunninghamh The Westmead Institute for Medical Research, University of Sydney, Sydney, AustraliaORCID Iconhttps://orcid.org/0000-0002-6744-5667View further author information
ORCID Icon show all
Pages 2628-2633 | Received 16 Dec 2019, Accepted 03 Mar 2020, Published online: 29 Apr 2020

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Agnes Mwakingwe-Omari, Nicolas Lecrenier, Abdi Naficy, Desmond Curran & Inga Posiuniene. (2023) Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies. Human Vaccines & Immunotherapeutics 19:3.
Read now
Marta Ulaszewska, Sarah Merelie, Sarah Sebastian & Teresa Lambe. (2023) Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster. Human Vaccines & Immunotherapeutics 19:1.
Read now
Joon Hyung Kim, John Diaz-Decaro, Ning Jiang, Shinn-Jang Hwang, Eun Ju Choo, Maribel Co, Andrew Hastie, David Shu Cheong Hui, Junya Irimajiri, Jacob Lee, Edward Man-Fuk Leung, Haiwen Tang, Tomomi Tsuru, Philip Watson, Zhenhua Wu, Chong-Jen Yu, Yanfei Yuan, Toufik Zahaf, Anthony L. Cunningham & Anne Schuind. (2021) The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials. Human Vaccines & Immunotherapeutics 17:7, pages 2050-2057.
Read now

Articles from other publishers (8)

Renate Zeevaert, Nancy Thiry, Charline Maertens de Noordhout & Dominique Roberfroid. (2023) Efficacy and safety of the recombinant zoster vaccine: A systematic review and meta-analysis. Vaccine: X 15, pages 100397.
Crossref
Myron J. Levin. 2023. Plotkin's Vaccines. Plotkin's Vaccines 1334 1349.e7 .
Wivine Burny, Caroline Hervé, Magalie Caubet, Juan Pablo Yarzabal & Arnaud M Didierlaurent. (2022) Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults. Vaccine 40:19, pages 2714-2722.
Crossref
Jürgen Held, Jan Esse, Koray Tascilar, Philipp Steininger, Kilian Schober, Pascal Irrgang, Rayya Alsalameh, Matthias Tenbusch, Christof Seggewies & Christian Bogdan. (2021) Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®). Vaccines 9:10, pages 1063.
Crossref
Courtney Gidengil, Matthew Bidwell Goetz, Sydne Newberry, Margaret Maglione, Owen Hall, Jody Larkin, Aneesa Motala & Susanne Hempel. (2021) Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine 39:28, pages 3696-3716.
Crossref
Anthony L Cunningham, Peter McIntyre, Kanta Subbarao, Robert Booy & Myron J Levin. (2021) Vaccines for older adults. BMJ, pages n188.
Crossref
Joseph Fiore, Maribel Miranda Co-van der Mee, Andrés Maldonado, Lisa Glasser & Phil Watson. (2021) Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance. Therapeutic Advances in Vaccines and Immunotherapy 9, pages 251513552110574.
Crossref
Myron J. Levin & Adriana Weinberg. 2023. Varicella-zoster Virus. Varicella-zoster Virus 223 246 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.